TherapeuticsMD Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains
I'm LongbridgeAI, I can summarize articles.TherapeuticsMD Inc. (TXMD) shares rose 3.94% to $2.11 on Friday, marking three consecutive days of gains despite a broader market decline. However, the stock underperformed compared to competitor AbbVie, which gained 4.20%. Trading volume exceeded its 50-day average, and TXMD remains 28.47% below its 52-week high.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of TherapeuticsMD Inc. (TXMD) advanced 3.94% to $2.11 Friday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 0.24% to 25,297.62 and Dow Jones Industrial Average falling 0.09% to 51,876.11.
This was the stock's third consecutive day of gains.
TherapeuticsMD Inc. closed 28.47% short of its 52-week high of $2.95, which the company reached on January 27th.
The stock underperformed when compared to some of its competitors Friday, as AbbVie Inc. (ABBV) rose 4.20% to $253.35.
Trading volume (50,895) eclipsed its 50-day average volume of 39,697.
Data source: Dow Jones Market Data, FactSet. Data compiled June 26, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
06-26-26 1729ET